2022

Annual Results Presentation

March 2023

Chapter I Annual Performance Review

Chapter II Macro Economy and Industry Policies

Chapter III Business Highlights and Future Strategies

Annual Performance

Review

The economies of scale grew steadily and the business structure has been continuously optimized

Unit: RMB million

Profitability grew effectively and operating efficiency accelerated to improve

Unit: RMB million

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Sinopharm Group Co. Ltd. published this content on 25 March 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 27 March 2023 10:27:02 UTC.